Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genesco (GCO) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Genesco (GCO) over the last 16 years, with Q4 2025 value amounting to -$2.9 million.

  • Genesco's Change in Accured Expenses rose 181.15% to -$2.9 million in Q4 2025 from the same period last year, while for Nov 2025 it was -$2.4 million, marking a year-over-year decrease of 13166.53%. This contributed to the annual value of $12.1 million for FY2025, which is 70000.0% up from last year.
  • Per Genesco's latest filing, its Change in Accured Expenses stood at -$2.9 million for Q4 2025, which was up 181.15% from $9.7 million recorded in Q3 2025.
  • Genesco's 5-year Change in Accured Expenses high stood at $33.8 million for Q2 2021, and its period low was -$44.2 million during Q2 2022.
  • Over the past 5 years, Genesco's median Change in Accured Expenses value was -$2.4 million (recorded in 2022), while the average stood at -$251350.0.
  • The largest annual percentage gain for Genesco's Change in Accured Expenses in the last 5 years was 31683.99% (2025), contrasted with its biggest fall of 60370.71% (2025).
  • Over the past 5 years, Genesco's Change in Accured Expenses (Quarter) stood at -$3.5 million in 2021, then skyrocketed by 141.33% to $1.4 million in 2022, then plummeted by 264.68% to -$2.4 million in 2023, then decreased by 25.36% to -$3.0 million in 2024, then increased by 1.81% to -$2.9 million in 2025.
  • Its last three reported values are -$2.9 million in Q4 2025, $9.7 million for Q3 2025, and -$15.2 million during Q2 2025.